Companies: 10,795·Total market cap: $144.5T
ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.

ACADNASDAQHealthcare● Active
$21.61
+$0.05(+0.23%)
Market Cap$3.7B
P/E Ratio
52W High$28.35
52W Low$19.69
Overview

ACADIA Pharmaceuticals Inc.(ACAD)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ACAD · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$1.07B$0.96B$0.73B$0.52B$0.48B
Cost of Revenue$0.09B$0.08B$0.05B$0.01B$0.02B
Gross Profit$0.98B$0.88B$0.68B$0.51B$0.47B
Gross Margin %(computed)91.69%91.46%93.70%98.03%96.05%
Operating Expenses
R&D Expenses$0.33B$0.30B$0.35B$0.36B$0.24B
G&A Expenses$0.00B$0.00B$0.39B$0.00B$0.40B
Total Operating Expenses$0.88B$0.65B$0.75B$0.73B$0.64B
Operating Income$0.10B$0.23B($0.07B)($0.22B)($0.17B)
Operating Margin %(computed)9.78%24.10%-10.10%-43.23%-35.20%
Interest Income$0.03B$0.03B$0.02B$0.01B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax$0.14B$0.26B($0.05B)($0.21B)($0.17B)
Income Tax Expense($0.25B)$0.03B$0.01B$0.00B$0.00B
Net Income$0.39B$0.23B($0.06B)($0.22B)($0.17B)
Net Margin %(computed)36.49%23.64%-8.44%-41.76%-34.67%
Per Share & EBITDA
EPS (Basic)$2.32$1.37$-0.37$-1.34$-1.05
Wtd Avg Shares0.17B0.17B0.16B0.16B0.16B
EBITDA$0.14B$0.10B($0.07B)($0.22B)($0.17B)
EBITDA Margin %(computed)12.96%10.46%-9.34%-42.84%-34.51%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解ACADIA Pharmaceuticals Inc.

关于ACADIA Pharmaceuticals Inc.(ACAD)损益表

ACADIA Pharmaceuticals Inc.(ACAD)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ACAD实现营收$1.07B,毛利润$0.98B(毛利率91.69%),净利润$0.39B(净利率36.49%)。

常见问题

ACAD · 4 问

ACADIA Pharmaceuticals Inc.(ACAD)2025财年营收为$1.07B,同比up11.9%。

ACAD revenueACAD salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08